| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | 0.039 | 0.3 |
| mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | lenalidomide | FIMM | pan-cancer | AAC | 0.18 | 0.3 |
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | -0.041 | 0.3 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | -0.052 | 0.3 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | -0.033 | 0.3 |
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | 0.049 | 0.3 |
| mRNA | triptolide | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | I-BET151 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.3 |
| mRNA | selumetinib:piperlongumine (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |